Indication

Hypoestrogenism due to bilateral oophorectomy

Hypoestrogenism due to bilateral oophorectomy refers to an endocrine deficiency state resulting from the surgical removal of both ovaries, which causes an abrupt cessation of ovarian estrogen biosynthesis. Read more about Hypoestrogenism due to bilateral oophorectomy

70 drugs 47 manufacturers

Advertisement

Drugs that treat it

Common Hypoestrogenism due to bilateral oophorectomy therapies.

Showing 19–27 of 70 drugs

Filter & compare in the drug finder →Opens the drug finder with Hypoestrogenism due to bilateral oophorectomy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypoestrogenism due to bilateral oophorectomy.

Hypoestrogenism due to bilateral oophorectomy refers to an endocrine deficiency state resulting from the surgical removal of both ovaries, which causes an abrupt cessation of ovarian estrogen biosynthesis.

This condition primarily affects premenopausal or perimenopausal females, inducing an immediate surgical menopause characterized by precipitous declines in systemic estradiol concentrations and a compensatory elevation in gonadotropins.

Clinically, it manifests with acute and often severe vasomotor symptoms, sleep disturbances, mood changes, and genitourinary atrophy.

Without physiologic estrogen replacement, this chronic hypoestrogenic state significantly elevates the long-term risk of accelerated bone mineral density loss leading to osteoporosis, cardiovascular disease, and adverse cognitive outcomes.

Personalize your experience

Follow Hypoestrogenism due to bilateral oophorectomy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it